Evidence map›Paper›PMID 19425824›Full record

ReviewFoodborne pathogens and disease2009

Novel approaches for Campylobacter control in poultry.

Jun Lin

Open access · greenAbstract readReview
In one paragraph

Review in Foodborne pathogens and disease, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 201 citations in OpenAlex.

  1. Observational
  2. Preharvest Control ofMicroorganisms · 2025
    Review
  3. The Global Challenge ofTropical medicine and infectious disease · 2025
    Review
  4. Consortium ofAntibiotics (Basel, Switzerland) · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Fecal Microbiota Transplantation ReducesAntibiotics (Basel, Switzerland) · 2023
    Article
  11. Review
  12. Proteotyping ofMicroorganisms · 2023
    Article
  13. Article
  14. Transmission pathways ofFrontiers in microbiology · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Phage Biocontrol of Campylobacter: A One Health Approach.Current topics in microbiology and immunology · 2021
    Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jun LinDepartment of Animal Science, The University of Tennessee, Knoxville, Tennessee 37996-4574, USA. jlin6@utk.edu
University of Tennessee at Knoxville · US

Funding

Development and evaluation of subunit vaccine CmeC against Campylobacter jejuniR21AI072551 · NIAID · UNIVERSITY OF TENNESSEE KNOXVILLE · PI LIN, JUN · 2007 to 2008
$329k
NIAID NIH HHS R21 AI072551-01A1
6 · The paper itself

Abstract

The Gram-negative bacterium Campylobacter is the most common bacterial cause of human gastroenteritis in the United States and many industrialized countries. Poultry, particularly chickens, is considered a major source of human campylobacteriosis. Thus, on-farm control of Campylobacter in poultry would reduce the risk of human exposure to this pathogen and have a significant impact on food safety and public health. To date, three general strategies have been proposed to control Campylobacter in poultry at the farm level: (1) reduction of environmental exposure (biosecurity measures), (2) an increase in poultry's host resistance to reduce Campylobacter carriage in the gut (e.g., competitive exclusion, vaccination, and host genetics selection), and (3) the use of antimicrobial alternatives to reduce and even eliminate Campylobacter from colonized chickens (e.g., bacteriophage therapy and bacteriocin treatment). Except for biosecurity measures, the other intervention approaches are currently not commercially available and are still under development. This review is focused on two promising strategies--vaccination and bacteriocin treatment. In particular, we extensively review recent research aimed at discovering and characterizing potent anti-Campylobacter bacteriocins to reduce Campylobacter load at the primary production level in poultry.

Indexed as

Animal HusbandryAnimalsBacterial VaccinesBacteriocinsCampylobacterCampylobacter InfectionsFoodborne DiseasesFood MicrobiologyHost-Pathogen InteractionsHumansMass VaccinationPoultryPoultry DiseasesBacterial VaccinesBacteriocins

Identifiers

PMID19425824
PMCPMC3145176
OpenAlexW1975352838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.